Tawasul
Mubasher TV
Contact Us Advertising   العربية

Kahira Pharmaceuticals posts 12% higher profit in nine months

Kahira Pharmaceuticals posts 12% higher profit in nine months
The sales grew to EGP 805.87 million in the period ended 31 March
Kahira Pharmaceuticals
CPCI
0.00% 37.00 0.00

Cairo – Mubasher: Kahira Pharmaceuticals achieved net profits of EGP 102.9 million in the first nine months of fiscal year (FY) 2020/2021, up by 11.6% year-on-year (YoY) from EGP 92.23 million, the unaudited financial results showed.

The sales grew to EGP 805.87 million in the nine-month period ended 31 March, compared to EGP 773.3 million in the corresponding period a year earlier, the company said in a bourse disclosure on Wednesday.

The profit growth was ascribed to higher local sales and exports of products.

During the first six months of FY20/21, the company reported net profits of EGP 67 million, up from EGP 56.77 million in the prior-year period.